Contrast Media and Reactions Practice Questions

Q: What is the diagnosis for this patient with end-stage renal disease who developed skin changes after an imaging procedure?

Nephrogenic systemic fibrosis. **Nephrogenic systemic fibrosis** * This condition is strongly associated with exposure to **gadolinium-based contrast agents** in patients with severe **renal insufficiency** or **end-stage renal disease (ESRD)**. * It presents with **skin thickening** and hardening, often involving the extremities and trunk, which can progress to joint contractures and immobility. *Porphyria cutanea tarda* * This is a **disorder of heme synthesis** characterized by **fragile skin**, **blistering**, and **hypertrichosis** in sun-exposed areas [1]. * While it can be associated with liver disease and sometimes seen in patients with ESRD, it is not directly linked to contrast media exposure [1]. *Calciphylaxis* * This severe and rare syndrome involves **vascular calcification** and **skin necrosis**, predominantly seen in patients with ESRD. * It typically presents as painful, violaceous skin lesions that progress to ulcers, and while connected to ESRD, it is not triggered by imaging procedures. *Actinic elastosis* * This condition refers to **degeneration of elastic tissue in the skin** due to chronic and excessive **sun exposure**. * It is characterized by thickened, wrinkled, and yellowed skin and is not related to kidney disease or contrast agent exposure.

Q: Which contrast agent is given in perforation peritonitis?

Diatrizoate. ***Diatrizoate*** - **Diatrizoate**, a **water-soluble iodinated contrast agent**, is safe for use in suspected bowel perforation because it is absorbed and excreted by the kidneys if it extravasates into the peritoneal cavity. - Unlike barium, it does not cause severe **peritoneal inflammation** or scarring if it leaks into the peritoneum. *Iohexol* - Iohexol is a **non-ionic, low-osmolar contrast medium** primarily used for intravascular administration or for imaging structures like the urinary tract or cerebral arteries. - While water-soluble, it is generally not the first choice for gastrointestinal perforations as **Diatrizoate** has a longer established safety profile and lower cost for this specific indication. *Metrizoate* - Metrizoate is an **ionic, high-osmolar contrast media** that is less commonly used today due to its higher osmolarity and potential for side effects compared to newer agents. - It could theoretically be used in perforation due to its water solubility, but its higher osmolality makes it less preferred than **Diatrizoate**, which is more readily available and widely accepted for this specific application. *Iodixanol* - Iodixanol is an **iso-osmolar, non-ionic contrast medium** mainly used for intravascular procedures, particularly in patients at risk of contrast-induced nephropathy. - While it is water-soluble and safer for intravascular use, it is generally not used for suspected bowel perforations due to its higher cost and the established efficacy and safety of **Diatrizoate** for this specific indication.

Q: Which of the following contrast agents is PREFERRED in a patient with renal dysfunction for the prevention of contrast-induced nephropathy?

Iso-osmolar contrast. ***Iso-osmolar contrast*** - **Iso-osmolar contrast agents** (e.g., iodixanol) have an osmolality of ~290 mOsm/kg, which is identical to that of plasma. - **This is the PREFERRED choice** in patients with renal dysfunction as multiple studies demonstrate the lowest risk of contrast-induced nephropathy (CIN). - The iso-osmolar formulation minimizes osmotic stress on renal tubules and reduces the risk of acute kidney injury. - **Current guidelines recommend iso-osmolar agents as first-line** in high-risk patients with pre-existing renal impairment. *Low osmolar contrast* - **Low osmolar contrast agents** have osmolality of 600-900 mOsm/kg, which is significantly lower than high osmolar agents but still 2-3 times higher than plasma. - While **acceptable and safer than high osmolar agents**, they are not as optimal as iso-osmolar contrast for patients with renal dysfunction. - These agents are widely used and represent a reasonable alternative when iso-osmolar agents are not available. *High osmolar contrast* - **High osmolar contrast agents** have osmolality >1400 mOsm/kg (about 5 times that of plasma). - They carry the **highest risk of contrast-induced nephropathy** due to severe osmotic load and direct tubular toxicity. - **Contraindicated or strongly avoided** in patients with pre-existing renal dysfunction. *Ionic contrast* - **Ionic contrast** refers to the chemical structure (dissociates into ions) rather than osmolality. - Can be either high or low osmolar—the ionic nature alone does not determine renal safety. - The critical factor for nephrotoxicity prevention is osmolality, not ionic charge.

Q: Which contrast agent is not used for CT scans?

CO2. ***CO2*** - **CO2** (carbon dioxide) is **not used as a contrast agent in CT scans**. - CO2 is primarily used in **angiography** (especially for peripheral vessels in patients with iodine allergy or renal insufficiency) where it acts as a negative contrast agent. - In CT, CO2 would appear as air/gas density and create artifacts rather than providing diagnostic enhancement, making it unsuitable for routine CT imaging. *Iodinated high-osmolality contrast media* - These are **iodinated contrast agents** that contain iodine atoms which strongly attenuate X-rays, making them highly effective for **CT imaging**. - High-osmolality contrast media (HOCM) like **diatrizoate** and **iothalamate** were the standard CT contrast agents historically. - They have largely been replaced by **low-osmolality** and **iso-osmolality** agents due to higher incidence of **adverse reactions**, but they are still used for CT scans. *Barium compounds* - **Barium sulfate** suspensions are widely used as **oral or rectal contrast agents** for CT imaging of the gastrointestinal tract. - Barium has high atomic number and effectively attenuates X-rays, making the **GI lumen clearly visible** on CT scans. - Used in **CT enterography**, **CT colonography**, and routine **abdominal/pelvic CT** protocols. *Gadolinium-based contrast agents* - **Gadolinium-based contrast agents (GBCAs)** are primarily designed for **MRI** due to their **paramagnetic properties**. - However, gadolinium DOES attenuate X-rays and can be used **off-label for CT** in patients with **severe iodine allergy** or **contraindications to iodinated contrast**. - While less effective than iodinated agents for CT (requiring higher doses), gadolinium-enhanced CT is a recognized alternative in special clinical circumstances.

Q: Which of the following is an example of a low-osmolar ionic contrast agent?

Ioxaglate. ***Ioxaglate*** - **Ioxaglate** is a **low-osmolar ionic dimer**, making it the correct answer to this question. - It dissociates into two iodine-bearing anions and one meglumine/sodium cation in solution. - Its dimeric structure carries six iodine atoms per molecule, and its ionic nature combined with low osmolarity distinguishes it from high-osmolar ionic agents. *Iothalamate* - **Iothalamate** is a **high-osmolar ionic monomer** contrast agent, not low-osmolar. - While it is ionic, it dissociates into one iodine-bearing anion and one meglumine/sodium cation (3 iodine atoms per molecule), resulting in higher osmolarity. - This makes it incorrect for this specific question about low-osmolar agents. *Iohexol* - **Iohexol** is a **non-ionic monomer** contrast agent. - It does not dissociate in solution, remaining as a neutral molecule with three iodine atoms per molecule. - While it is low-osmolar, it is non-ionic, not ionic. *None of the options* - This option is incorrect because **Ioxaglate** is indeed an example of a low-osmolar ionic contrast agent. - Low-osmolar ionic agents like Ioxaglate provide better tolerability compared to high-osmolar ionic agents while maintaining ionic properties.

Q: Which of the following is a non-ionic contrast agent?

Iohexol. ***Iohexol*** - **Iohexol** is a well-known example of a **non-ionic, low osmolar contrast agent**. It's widely used due to its lower incidence of adverse reactions compared to ionic agents. - Non-ionic contrast agents remain as **intact molecules** in solution and do not dissociate into charged ions, contributing to their lower osmolality and better tolerability. *Amidotrizoate* - **Amidotrizoate** (also known as diatrizoate) is an **ionic, high osmolar contrast agent**. It dissociates into two ions in solution. - Due to its high osmolality, it is associated with a higher risk of adverse effects, such as **nausea**, **vomiting**, and **nephrotoxicity**. *Iothalamate* - **Iothalamate** is another example of an **ionic, high osmolar contrast agent**. It also dissociates into charged ions when dissolved. - Its use has decreased significantly with the development of safer non-ionic alternatives due to its higher potential for **adverse drug reactions**. *Ioxoglate* - **Ioxoglate** is a **dimeric, ionic contrast agent**. Although it's ionic, it has a lower osmolality than monomeric ionic agents due to its dimeric structure. - Despite being dimeric, it still dissociates into ions, distinguishing it from truly non-ionic compounds like iohexol.

Q: Which of the following is Iso-osmolar agent?

Non-ionic Dimer contrast media. ***Non-ionic Dimer contrast media*** - **Iodixanol** is the only available non-ionic dimer contrast agent, and it is **iso-osmolar** with blood plasma (290 mOsm/kg). - Its iso-osmolality contributes to a lower incidence of adverse reactions, particularly in patients at high risk. *Ionic Monomer - High osmolality contrast media* - These agents have an osmolality significantly higher than that of blood plasma, often 6-8 times greater. - High osmolality leads to a higher incidence of adverse effects due to cellular fluid shifts and direct endothelial damage. *Non-ionic Monomer - Low osmolality contrast media* - These agents have an osmolality lower than ionic monomers but are still hyperosmolar compared to blood plasma (typically 2-3 times higher). - While generally safer than high-osmolality agents, they can still cause discomfort and adverse reactions due to their hyperosmolality. *Ionic Dimer - Low osmolality contrast media* - Ionic dimers, such as **ioxaglate**, are considered low-osmolality agents but are still hyperosmolar relative to plasma. - They feature two benzene rings with iodine atoms and are salts, contributing to their osmolality.

Q: Enhancement in CT contrast is due to -

Iodine. ***Iodine*** - **Iodine-based contrast agents** are commonly used in CT scans to enhance the visualization of blood vessels, organs, and certain lesions due to their **high atomic number** and ability to absorb X-rays. - The degree of enhancement observed on a CT image is directly proportional to the concentration of **iodine** in the tissue or blood. *Gadolinium* - **Gadolinium-based contrast agents** are predominantly used in **Magnetic Resonance Imaging (MRI)**, not CT scans. - Gadolinium works by altering the **magnetic properties** of water molecules in tissues, thereby improving MRI signal intensity. *Mercury* - **Mercury** is a highly toxic heavy metal and is **not used as a contrast agent** in any imaging modality due to its severe health risks. - While historically used in some medical applications, it has been replaced by safer alternatives. *Silver* - **Silver** is not used as a contrast agent in medical imaging; it has no suitable properties for enhancing images in CT or other common modalities. - It is known for its **antimicrobial properties** and is sometimes used in wound dressings.

Q: Which type of contrast agent is considered safe for use in patients with chronic kidney disease?

Ultrasound contrast. ***Ultrasound contrast*** - **Ultrasound contrast agents**, particularly those containing **microbubbles**, are considered safe for renal patients as they are not excreted via the kidneys. - These agents are broken down and excreted primarily through the **respiratory system**, posing minimal risk to kidney function. *Non-ionic iodinated contrast* - While generally safer than ionic alternatives, **non-ionic iodinated contrast agents** still carry a risk of **contrast-induced nephropathy (CIN)** in patients with **CKD**. - Renal excretion is the primary route of elimination, requiring careful consideration and prophylactic measures in individuals with **impaired renal function**. *Gadolinium* - **Gadolinium-based contrast agents** are associated with the risk of **nephrogenic systemic fibrosis (NSF)** in patients with **severe chronic kidney disease** or **acute kidney injury**. - Although newer macrocyclic agents have a lower risk, it is still generally avoided in renal patients unless absolutely necessary due to its **renal excretion**. *Ionic iodinated contrast* - **Ionic iodinated contrast agents** have a higher osmolality and are strongly associated with a greater risk of **contrast-induced nephropathy (CIN)** compared to non-ionic agents. - Their significant **renal toxicity** makes them largely contraindicated in patients with **pre-existing chronic kidney disease**.

Question 1

What is the diagnosis for this patient with end-stage renal disease who developed skin changes after an imaging procedure?

Accepted Answer

Nephrogenic systemic fibrosis

Answer

Porphyria cutanea tarda

Answer

Calciphylaxis

Answer

Actinic elastosis

Question 2

Which of the following statements about contrast media in radiology is true?

Accepted Answer

Ionic monomers have three iodine atoms per two particles in solution

Answer

Iohexol is a high osmolar contrast media

Answer

Non-ionic contrast agents are always high osmolar

Answer

Gadolinium can cross an intact blood brain barrier

Question 3

Which contrast agent is given in perforation peritonitis?

Accepted Answer

Diatrizoate

Answer

Iohexol

Answer

Metrizoate

Answer

Iodixanol

Question 4

Which of the following contrast agents is PREFERRED in a patient with renal dysfunction for the prevention of contrast-induced nephropathy?

Accepted Answer

Iso-osmolar contrast

Answer

High osmolar contrast

Answer

Ionic contrast

Answer

Low osmolar contrast

Question 5

Which contrast agent is not used for CT scans?

Accepted Answer

CO2

Answer

Iodinated high-osmolality contrast media

Answer

Barium compounds

Answer

Gadolinium-based contrast agents

Question 6

Which of the following is an example of a low-osmolar ionic contrast agent?

Accepted Answer

Ioxaglate

Answer

Iothalamate

Answer

Iohexol

Answer

None of the options

Question 7

Which of the following is a non-ionic contrast agent?

Accepted Answer

Iohexol

Answer

Amidotrizoate

Answer

Iothalamate

Answer

Ioxoglate

Question 8

Which of the following is Iso-osmolar agent?

Accepted Answer

Non-ionic Dimer contrast media

Answer

Ionic Monomer - High osmolality contrast media

Answer

Non-ionic Monomer - Low osmolality contrast media

Answer

Ionic Dimer - Low osmolality contrast media

Question 9

Enhancement in CT contrast is due to -

Accepted Answer

Iodine

Answer

Gadolinium

Answer

Mercury

Answer

Silver

Question 10

Which type of contrast agent is considered safe for use in patients with chronic kidney disease?

Accepted Answer

Ultrasound contrast

Answer

Non-ionic iodinated contrast

Answer

Gadolinium

Answer

Ionic iodinated contrast

Contrast Media and Reactions — MCQs

Contrast Media and Reactions — MCQs

On this page

Practice by Chapter

Want unlimited practice?